-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$56.1017.66% Upside
Recent Analyst Forecasts and Stock Ratings
Biohaven Pharmaceutical Holding Company Ltd. Frequently Asked Questions
-
What analysts cover Biohaven Pharmaceutical Holding Company Ltd.?
Biohaven Pharmaceutical Holding Company Ltd. has been rated by research analysts at Leerink Partners, H.C. Wainwright, Bank of America Securities, RBC Capital, BTIG, Robert W. Baird in the past 90 days.